Fresh Off the Maui Derm Podium: Guselkumab Shows Significant Skin Clearance in Special PsO Sites
Guselkumab (Tremfya, Johnson & Johnson) is highly effective in psoriasis patients with low body surface area (BSA), moderate plaque psoriasis with involvement of special sites, according to research presented at 2025 Maui Derm Hawaii meeting. The new study was selected as a late breaker top five finalist for the best poster Akamai Award at the […]